Karnataka cuts NSQ drug recall time from 30 days to 3 days
Aug 8, 2025


Source: Pharmabiz
Share:
The Karnataka government has reduced the withdrawal timeline for not-of-standard quality (NSQ) medicines from 30 days to just 3 days, aiming to improve patient safety and ensure prompt market recalls. The move places greater accountability on manufacturers and distributors to uphold quality standards.
Key highlights
Faster recall process
Withdrawal timeline for NSQ drugs cut from 30 days to 3 days.
Intended to prevent prolonged circulation of substandard medicines in the market.
Recent enforcement actions
59 samples declared NSQ after routine inspections and lab testing.
29 legal cases filed in July 2025 against companies violating the Drugs and Cosmetics Act & Rules.
Substandard drugs worth ₹40 lakh recalled in July alone.
Public safety measures
FDA has warned retailers, wholesalers, and hospital pharmacies against stocking NSQ drugs.
Public advised not to purchase these medicines; doctors urged to avoid prescribing them.
Show-cause notices issued to 231 pharmacies for selling antibiotics and sedatives without prescriptions.
Range of affected medicines
Includes antipyretics, diabetes and hypertension medicines, cardiac drugs, antibiotics, gastrointestinal treatments, vitamins, and injectables.
Examples: Panoxen, povidone iodine solution, cefixime, sodium chloride injections, rosuvastatin, pantoprazole, telmisartan, adrenaline bitartrate injections, sodium valproate.
Regulatory oversight
NSQ drugs fail to meet quality standards for purity, strength, dissolution rate, or labelling accuracy.
Identified drugs are tested at the State Drug Test Lab, with manufacturers issued warnings to rectify manufacturing processes.
Surveillance to continue under Karnataka’s Health and Family Welfare Department to ensure drug safety and compliance.
Karnataka’s decision to drastically cut recall timelines for NSQ medicines underscores its commitment to consumer safety and strict regulatory enforcement. The faster process aims to protect patients from compromised drugs while holding pharmaceutical companies to higher quality standards.
Read next
Read next
Gujarat to launch SOP against fake medicines with zero tolerance policy
Gujarat to launch SOP against fake medicines with zero tolerance policy
Aug 7, 2025
Aug 7, 2025


Karnataka defends closure of Jan Aushadhi Kendras in government hospitals
Karnataka defends closure of Jan Aushadhi Kendras in government hospitals
Aug 7, 2025
Aug 7, 2025


Delhi police busts interstate fake medicine racket operating across 6 states
Delhi police busts interstate fake medicine racket operating across 6 states
Aug 7, 2025
Aug 7, 2025


Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved

Source: Pharmabiz
The Karnataka government has reduced the withdrawal timeline for not-of-standard quality (NSQ) medicines from 30 days to just 3 days, aiming to improve patient safety and ensure prompt market recalls. The move places greater accountability on manufacturers and distributors to uphold quality standards.
Key highlights
Faster recall process
Withdrawal timeline for NSQ drugs cut from 30 days to 3 days.
Intended to prevent prolonged circulation of substandard medicines in the market.
Recent enforcement actions
59 samples declared NSQ after routine inspections and lab testing.
29 legal cases filed in July 2025 against companies violating the Drugs and Cosmetics Act & Rules.
Substandard drugs worth ₹40 lakh recalled in July alone.
Public safety measures
FDA has warned retailers, wholesalers, and hospital pharmacies against stocking NSQ drugs.
Public advised not to purchase these medicines; doctors urged to avoid prescribing them.
Show-cause notices issued to 231 pharmacies for selling antibiotics and sedatives without prescriptions.
Range of affected medicines
Includes antipyretics, diabetes and hypertension medicines, cardiac drugs, antibiotics, gastrointestinal treatments, vitamins, and injectables.
Examples: Panoxen, povidone iodine solution, cefixime, sodium chloride injections, rosuvastatin, pantoprazole, telmisartan, adrenaline bitartrate injections, sodium valproate.
Regulatory oversight
NSQ drugs fail to meet quality standards for purity, strength, dissolution rate, or labelling accuracy.
Identified drugs are tested at the State Drug Test Lab, with manufacturers issued warnings to rectify manufacturing processes.
Surveillance to continue under Karnataka’s Health and Family Welfare Department to ensure drug safety and compliance.
Karnataka’s decision to drastically cut recall timelines for NSQ medicines underscores its commitment to consumer safety and strict regulatory enforcement. The faster process aims to protect patients from compromised drugs while holding pharmaceutical companies to higher quality standards.
Share:
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved